Evidence map›Paper›PMID 38905325›Full record

ArticleScience immunology2024

MAIT cells monitor intestinal dysbiosis and contribute to host protection during colitis.

Yara El Morr, Mariela Fürstenheim, Martin Mestdagh, Katarzyna Franciszkiewicz, Marion Salou, Claire Morvan, Thierry Dupré, Alexey Vorobev, Bakhos Jneid, Virginie Premel and 13 more

Abstract read
In one paragraph

Article in Science immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Gut archaea drive human MAIT cell responses.bioRxiv : the preprint server for biology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Avoidance of MAIT cells is an essential determinant ofProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Yara El MorrInstitut Curie, PSL University, Inserm U932, Immunity and Cancer, Paris, France.ORCID 0009-0003-5209-5793
Mariela FürstenheimInstitut Curie, PSL University, Inserm U932, Immunity and Cancer, Paris, France.ORCID 0000-0002-7741-0775
Martin MestdaghInstitut Curie, PSL University, Inserm U932, Immunity and Cancer, Paris, France.ORCID 0000-0001-7558-8628
Katarzyna FranciszkiewiczInstitut Curie, PSL University, Inserm U932, Immunity and Cancer, Paris, France.ORCID 0009-0002-9364-6152
Marion SalouInstitut Curie, PSL University, Inserm U932, Immunity and Cancer, Paris, France.ORCID 0000-0003-3546-0886
Claire MorvanInstitut Pasteur, Université Paris Cité, UMR CNRS 6047, Laboratoire Pathogenèse des Bactéries Anaérobies, F-75015 Paris, France.ORCID 0000-0001-8435-0523
Thierry DupréLaboratoire de Biochimie, Hôpital Bichat AP-HP, Université de Paris, Paris, France.ORCID 0000-0003-3081-944X
Alexey VorobevInstitut Curie, PSL University, Inserm U932, Immunity and Cancer, Paris, France.ORCID 0000-0002-2157-8747
Bakhos JneidInstitut Curie, PSL University, Inserm U932, Immunity and Cancer, Paris, France.ORCID 0000-0003-2158-4407
Virginie PremelInstitut Curie, PSL University, Inserm U932, Immunity and Cancer, Paris, France.
Aurélie DarboisInstitut Curie, PSL University, Inserm U932, Immunity and Cancer, Paris, France.ORCID 0000-0003-3022-8981
Laetitia PerrinInstitut Curie, PSL University, Inserm U932, Immunity and Cancer, Paris, France.ORCID 0009-0003-0633-6111
Stanislas MondotInstitut Micalis, INRAE, AgroParisTech, Université Paris-Saclay, Jouy-en-Josas, France.ORCID 0000-0003-3668-3168
Ludovic ColombeauCNRS UMR 3666, INSERM U1143, Chemical Biology of Cancer Laboratory, PSL University, Institut Curie, 75005 Paris, France.ORCID 0000-0001-5823-2603
Hélène BugautInstitut Curie, PSL University, Inserm U932, Immunity and Cancer, Paris, France.ORCID 0000-0002-5138-4951
Anastasia du HalgouetInstitut Curie, PSL University, Inserm U932, Immunity and Cancer, Paris, France.ORCID 0000-0001-8013-3716
Sophie RichonInstitut Curie, PSL Research University, CNRS UMR144, Paris, France.
Emanuele ProcopioInstitut Curie, PSL University, Inserm U932, Immunity and Cancer, Paris, France.
Mathieu MaurinInstitut Curie, PSL University, Inserm U932, Immunity and Cancer, Paris, France.ORCID 0000-0003-3555-6247
Catherine PhilippeInstitut Micalis, INRAE, AgroParisTech, Université Paris-Saclay, Jouy-en-Josas, France.
Raphael RodriguezCNRS UMR 3666, INSERM U1143, Chemical Biology of Cancer Laboratory, PSL University, Institut Curie, 75005 Paris, France.ORCID 0000-0001-7668-446X
Olivier LantzInstitut Curie, PSL University, Inserm U932, Immunity and Cancer, Paris, France.ORCID 0000-0003-3161-7719
François LegouxInstitut Curie, PSL University, Inserm U932, Immunity and Cancer, Paris, France.ORCID 0000-0003-4304-7637

Funding

European Research Council 885435
6 · The paper itself

Abstract

Intestinal inflammation shifts microbiota composition and metabolism. How the host monitors and responds to such changes remains unclear. Here, we describe a protective mechanism by which mucosal-associated invariant T (MAIT) cells detect microbiota metabolites produced upon intestinal inflammation and promote tissue repair. At steady state, MAIT ligands derived from the riboflavin biosynthesis pathway were produced by aerotolerant bacteria residing in the colonic mucosa. Experimental colitis triggered luminal expansion of riboflavin-producing bacteria, leading to increased production of MAIT ligands. Modulation of intestinal oxygen levels suggested a role for oxygen in inducing MAIT ligand production. MAIT ligands produced in the colon rapidly crossed the intestinal barrier and activated MAIT cells, which expressed tissue-repair genes and produced barrier-promoting mediators during colitis. Mice lacking MAIT cells were more susceptible to colitis and colitis-driven colorectal cancer. Thus, MAIT cells are sensitive to a bacterial metabolic pathway indicative of intestinal inflammation.

Indexed as

ColitisDysbiosisGastrointestinal MicrobiomeMice, Inbred C57BLMucosal-Associated Invariant T CellsAnimalsIntestinal MucosaMiceMice, KnockoutRiboflavinRiboflavin

Identifiers

PMID38905325
PMCPMC7616241

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.